Please login to the form below

Not currently logged in
Email:
Password:

Stallergenes

This page shows the latest Stallergenes news and features for those working in and with pharma, biotech and healthcare.

Merck gets US green light for allergy immunotherapy

Merck gets US green light for allergy immunotherapy

Grastek is the second allergy immunotherapy (AIT) product to be cleared for marketing in the US after Stallergenes' Oralair, which was approved last month.

Latest news

  • FDA backs a brace of allergy immunotherapies FDA backs a brace of allergy immunotherapies

    Stallergenes recently signed a deal with Greer, granting the latter exclusive commercialisation rights to Oralair in the US. ... Meanwhile for Stallergenes - with annual sales of around 250m - the upside could be significant.

  • Inducing immunity

    Hot on the heels of Grazax is Stallergenes' Oralair Grasses, which is expected to be launched in Europe in 2007.

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Stallergenes appoints Christian Chavy CEO Stallergenes appoints Christian Chavy CEO

    Christian Chavy has been appointed CEO of French biopharmaceutical company Stallergenes and will take over from Roberto Gradnik at the end of this month. . ... Stallergenes said Chavy's appointment would enable it to “pursue its strategy” and to its

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest from PMHub

  • Cogora

    Reckitt Benckiser. Stallergenes. Sun Pharma. Takeda. ThermoFisher Scientific. Vertex.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics